about
DNA Nanostructures on Membranes as Tools for Synthetic BiologyToward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challengesKey amino acid residues of ankyrin-sensitive phosphatidylethanolamine/phosphatidylcholine-lipid binding site of βI-spectrin.Membrane targeting of the Spir·formin actin nucleator complex requires a sequential handshake of polar interactionsSpectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells.Spectrin-phospholipid interactions. Existence of multiple kinds of binding sites?Oral cyclosporine A--the current picture of its liposomal and other delivery systems.Calcium Directly Regulates Phosphatidylinositol 4,5-Bisphosphate Headgroup Conformation and Recognition.Do we already know how spectrin attracts ankyrin?Validity and applicability of membrane model systems for studying interactions of peripheral membrane proteins with lipids.Spectrin and phospholipids - the current picture of their fascinating interplay.Amphipathic DNA origami nanoparticles to scaffold and deform lipid membrane vesicles.Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.Dystrophin and Spectrin, Two Highly Dissimilar Sisters of the Same Family.Protein palmitoylation: Palmitoyltransferases and their specificity.Fluorescence approach to evaluating conformational changes upon binding of beta-spectrin ankyrin-binding domain mutants with the lipid bilayer.Switchable domain partitioning and diffusion of DNA origami rods on membranes.A protein isolated from Escherichia coli, identified as GroEL, reacts with anti-beta spectrin antibodies.MPP1 directly interacts with flotillins in erythrocyte membrane - Possible mechanism of raft domain formation.Spatiotemporal Control of Lipid Conversion, Actin-Based Mechanical Forces, and Curvature Sensors during Clathrin/AP-1-Coated Vesicle Biogenesis.Phospholipid-induced structural changes to an erythroid beta spectrin ankyrin-dependent lipid-binding site.Morphological features of fascia lata in relation to fascia diseases.New lipid formulation of octenidine dihydrochloride.The role of hydrophobic interactions in ankyrin–spectrin complex formationPhosphatidic acid - a simple phospholipid with multiple facesDNA Origami Nanoneedles on Freestanding Lipid Membranes as a Tool To Observe Isotropic–Nematic Transition in Two DimensionsDEL-1 promotes macrophage efferocytosis and clearance of inflammationStructural insight into an ankyrin-sensitive lipid-binding site of erythroid beta-spectrinProperties of Lipid Models of Lung Surfactant Containing Cholesterol and Oxidized Lipids: A Mixed Experimental and Computational StudyEGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers
P50
Q26749392-E356F04A-6A32-4101-BB26-24E7702C038EQ26995399-244F9307-BB51-477C-853F-C91C6143A87CQ33955023-74730152-55DF-4DDC-A075-826230BA60A5Q35172987-B69237B8-8075-4520-A2D5-0203198741B2Q36180675-CC3382D0-213F-4B53-9C11-049896CA74AFQ36432926-6398A706-99D2-4B7D-A7EC-CDEA1DD90A1AQ37324276-B4AD54AF-1CFC-4BEC-81DA-0AF0CC34C51DQ37719354-1E4A63D0-0636-4D1A-84A7-86A126D9FD3AQ37735740-76D77E7E-6CDD-43E2-9637-F68BDC9464D5Q38174409-D1510B88-1801-4C95-9559-B8C68A1ABA85Q38191168-6019900C-0FE0-482B-950A-6CA4AB91DFF4Q38299727-83301A78-DB50-48B6-AF76-A3CF89B8DEFFQ38818296-03DB2F0B-991B-4E8A-BC99-6C5151A450FEQ39094614-6013DD37-747A-4F39-8CA1-04B5D62D28A3Q39293414-98011AD3-66F6-4194-8673-7448D7D8A8B5Q43206895-A13B19EE-0302-4861-9572-3F0503F8CBC7Q43749386-B43E2049-AAC0-4F7F-9349-54647A444CD8Q44474754-40915746-B402-4056-BED6-8258AF06D027Q47865530-F43ACE10-7412-4657-A7BD-507EAF51E8F0Q47883378-DC2D1DE0-EB79-423C-84A2-EB2C2ABCC4A6Q48324720-1EB73C54-0B83-4D56-BE5A-2A1B4C9474DAQ51131948-10EB6801-33BD-4420-B931-5AE8F5ADE3FAQ53615800-33B479DB-B1FA-4634-88BE-BCA7BC79ACF2Q56837924-E5E3D6D6-0FD2-4E46-987C-1F02C1F4BAFBQ57133268-FD1A1288-6D04-4291-9907-36CA9F5EECBDQ61908333-F0983453-A7D7-4F0A-9891-B93D394DF793Q63546850-C73396FA-7D12-48FE-9C1D-D85892F8C110Q80372284-B4A58A83-9B17-410A-899A-3BBCEFFBFB2EQ92418826-33C1CAB7-FAD0-45B7-BD5C-6EB764869D36Q92540122-A6C5773D-79B7-41D9-9E77-DE3B5EC39FB4
P50
description
Biolog molekularny
@pl
Molecular biologist
@en
Pools onderzoeker
@nl
investigador polacu
@ast
polnischer Forscher
@de
name
Aleksander Czogalla
@ast
Aleksander Czogalla
@ca
Aleksander Czogalla
@de
Aleksander Czogalla
@en
Aleksander Czogalla
@es
Aleksander Czogalla
@fr
Aleksander Czogalla
@ga
Aleksander Czogalla
@it
Aleksander Czogalla
@nl
Aleksander Czogalla
@pl
type
label
Aleksander Czogalla
@ast
Aleksander Czogalla
@ca
Aleksander Czogalla
@de
Aleksander Czogalla
@en
Aleksander Czogalla
@es
Aleksander Czogalla
@fr
Aleksander Czogalla
@ga
Aleksander Czogalla
@it
Aleksander Czogalla
@nl
Aleksander Czogalla
@pl
prefLabel
Aleksander Czogalla
@ast
Aleksander Czogalla
@ca
Aleksander Czogalla
@de
Aleksander Czogalla
@en
Aleksander Czogalla
@es
Aleksander Czogalla
@fr
Aleksander Czogalla
@ga
Aleksander Czogalla
@it
Aleksander Czogalla
@nl
Aleksander Czogalla
@pl
P1053
A-9752-2014
P1153
6506016689
P1412
P1559
Aleksander Czogalla
@pl
P2038
Aleksander_Czogalla
P21
P214
291144782720117209006
P27
P31
P3124
P3829
P3835
aleksander-czogalla
P496
0000-0003-3035-059X
P735
P7859
viaf-291144782720117209006